Toward the validation of aneusomy detection by fluorescence in situ hybridization in bladder cancer: comparative analysis with cytology, cytogenetics, and clinical features predicts recurrence and defines clinical testing limitations

scientific article published in December 1997

Toward the validation of aneusomy detection by fluorescence in situ hybridization in bladder cancer: comparative analysis with cytology, cytogenetics, and clinical features predicts recurrence and defines clinical testing limitations is …
instance of (P31):
scholarly articleQ13442814

External links are
P698PubMed publication ID9815630

P2093author name stringSlovak ML
Arber DA
Wilson TG
Kawachi MH
Zhang FF
P4510describes a project that usesfluorescence in situ hybridizationQ1336182
P433issue12 Pt 1
P407language of work or nameEnglishQ1860
P921main subjectcytogeneticsQ246128
P304page(s)2317-2328
P577publication date1997-12-01
P1433published inClinical Cancer ResearchQ332253
P1476titleToward the validation of aneusomy detection by fluorescence in situ hybridization in bladder cancer: comparative analysis with cytology, cytogenetics, and clinical features predicts recurrence and defines clinical testing limitations
P478volume3

Reverse relations

cites work (P2860)
Q40612941A pilot study of urinary microRNA as a biomarker for urothelial cancer
Q40166464Detection of bladder cancer from the urine using fluorescence in situ hybridization technique.
Q39693001One-year monitoring of an oligonucleotide fluorescence in situ hybridization probe panel laboratory-developed test for bladder cancer detection
Q33367131Somatic pairing of chromosome 19 in renal oncocytoma is associated with deregulated EGLN2-mediated [corrected] oxygen-sensing response
Q42721217The development of a multitarget, multicolor fluorescence in situ hybridization assay for the detection of urothelial carcinoma in urine